Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 766 AL 780

Cognitive impairment in Parkinson's disease is multifactorial: A neuropsychological study

Smith CR, Cullen B, Sheridan MP, Cavanagh J, Grosset KA, Grosset DG.

Acta Neurol Scand. 2020 Jun;141(6):500-508. doi: 10.1111/ane.13226. Epub 2020 Feb 27.

In search of Parkinson's disease biomarkers - is the answer in our mouths? A systematic review of the literature on salivary biomarkers of Parkinson's disease

Figura M, Friedman A.

Neurol Neurochir Pol. 2020;54(1):14-20. doi: 10.5603/PJNNS.a2020.0011. Epub 2020 Jan 31.

The Main Targets Involved in Neuroprotection for the Treatment of Alzheimer's Disease and Parkinson Disease

Gülcan HO, Orhan IE.

Curr Pharm Des. 2020;26(4):509-516. doi: 10.2174/1381612826666200131103524.

Do mobile device apps designed to support medication adherence demonstrate efficacy? A systematic review of randomised controlled trials, with meta-analysis

Armitage LC, Kassavou A, Sutton S.

BMJ Open. 2020 Jan 30;10(1):e032045. doi: 10.1136/bmjopen-2019-032045.

Improving access to palliative care for persons with Parkinson disease

Ramanathan U, Tanuseputro P.

Ann Palliat Med. 2020 Mar;9(2):149-151. doi: 10.21037/apm.2019.11.10. Epub 2020 Jan 3.

Specialist palliative care for Parkinson's disease

Oliver D, Veronese S.

Ann Palliat Med. 2020 Feb;9(Suppl 1):S52-S62. doi: 10.21037/apm.2019.12.01. Epub 2020 Jan 24.

Levodopa-Responsive Primary Slow Orthostatic Tremor: A Premotor Sign of Parkinson's Disease?

Yoshii F, Takahashi W, Aono K.

Case Rep Neurol. 2020 Jan 3;12(1):1-6. doi: 10.1159/000504798. eCollection 2020 Jan-Apr.

Inhaled levodopa for intermittent treatment of OFF episodes in patients with Parkinson's disease

Simões RM, Castro Caldas A, Ferreira JJ.

Expert Rev Clin Pharmacol. 2020 Feb;13(2):85-101. doi: 10.1080/17512433.2020.1724535. Epub 2020 Feb 14.

Shaping the mitochondrial inner membrane in health and disease

Colina-Tenorio L, Horten P, Pfanner N, Rampelt H.

J Intern Med. 2020 Jun;287(6):645-664. doi: 10.1111/joim.13031. Epub 2020 Feb 26.

Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease

Teixeira FG, Vilaça-Faria H, Domingues AV, Campos J, Salgado AJ.

Cells. 2020 Jan 28;9(2):315. doi: 10.3390/cells9020315.

Circadian rhythms, Neuroinflammation and Oxidative Stress in the Story of Parkinson's Disease

Vallée A, Lecarpentier Y, Guillevin R, Vallée JN.

Cells. 2020 Jan 28;9(2):314. doi: 10.3390/cells9020314.

Copper Ions and Parkinson's Disease: Why Is Homeostasis So Relevant?

Bisaglia M, Bubacco L.

Biomolecules. 2020 Jan 29;10(2):195. doi: 10.3390/biom10020195.

Synthesis of Cerium Oxide Nanoparticles Using Various Methods: Implications for Biomedical Applications

Nyoka M, Choonara YE, Kumar P, Kondiah PPD, Pillay V.

Nanomaterials (Basel). 2020 Jan 29;10(2):242. doi: 10.3390/nano10020242.

Brain targeting with docosahexaenoic acid as a prospective therapy for neurodegenerative diseases and its passage across blood brain barrier

Hachem M, Belkouch M, Lo Van A, Picq M, Bernoud-Hubac N, Lagarde M.

Biochimie. 2020 Mar;170:203-211. doi: 10.1016/j.biochi.2020.01.013. Epub 2020 Jan 31.

RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease

Ahlers-Dannen KE, Spicer MM, Fisher RA.

Mol Pharmacol. 2020 Dec;98(6):730-738. doi: 10.1124/mol.119.118836. Epub 2020 Feb 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias